In vitro activity of rifampicin against Helicobacter pylori isolated from children and adults

Journal of Antimicrobial Chemotherapy

Volumn 49, Issue 3, 2002, Pages 541-543

  Fujimura, Shigeru ^a   Kato, Seiichi ^b   Kawamura, Takeshi ^c   Watanabe, Akira ^a  

^a MIYAGI UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; RIFAMPICIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CHILD; CONTROLLED STUDY; DRUG EXPOSURE; DRUG STABILITY; DRUG USE; HELICOBACTER PYLORI; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; TREATMENT FAILURE;

EID: 0036121136     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/49.3.541     Document Type: Article

References (10)

1. The MACH 2 study: Role of omeprazole in eradication of Helicobacter pylori with 1 week triple therapies
2. Current European concepts in the management of Helicobacter pylori infection: The Maastricht Consensus Report
3. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole and amoxicillin: Influence on treatment outcome
4. Drug therapy for Helicobacter pylori infection: Problems and pitfalls
5. In vitro activity of rifabutin against strains of Helicobacter pylori resistant to metronidazole and clarithromycin
6. Rifampin and rifabutin resistance mechanism in Helicobacter pylori
7. Antibiotic susceptibility of H. pylori in Europe in 1998: Results of the third multicentre study
8. Rifampicin: A new rifamycin: Absorption, distribution, and elimination in man
9. Helicobacter pylori infection rate in patients treated with rifampicin: Eradication effect of rifampicin on Helicobacter pylori